Aggregation of amyloids in a cellular context: modelling and experiment.

@article{Friedman2011AggregationOA,
  title={Aggregation of amyloids in a cellular context: modelling and experiment.},
  author={Ran Friedman},
  journal={The Biochemical journal},
  year={2011},
  volume={438 3},
  pages={
          415-26
        }
}
  • R. Friedman
  • Published 15 September 2011
  • Biology
  • The Biochemical journal
Amyloid-related diseases are a group of illnesses in which an abnormal accumulation of proteins into fibrillar structures is evident. Results from a wide range of studies, ranging from identification of amyloid-β dimers in the brain to biophysical characterization of the interactions between amyloidogenic peptides and lipid membranes during fibril growth shed light on the initial events which take place during amyloid aggregation. Accounts of fibril disaggregation and formation of globular… 

Figures and Tables from this paper

Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors
TLDR
It is demonstrated that in vitro refolding of Aβ42 inclusion bodies is selectively sensitive to the presence of aggregation-promoting metal ions, allowing the detection of inhibitors of metal-promoted amyloid aggregation with potential therapeutic interest.
Computational modeling of the relationship between amyloid and disease
TLDR
A substantial gap exists between computational and experimental communities with a deficit of ‘useful’ computational methodology that can be directly related to available markers of disease progression.
Identification of a common binding mode for imaging agents to amyloid fibrils from molecular dynamics simulations.
TLDR
Several binding modes are identified across the different ligand scaffolds, however a common favorable binding mode can be identified in which the agent is placed in surface grooves along the amyloid fibril axis, resulting in fine tuning of the binding affinities for a specific amyloids fibrils.
Single-Molecule Studies of Amyloidogenic Proteins
TLDR
This chapter focuses primarily on single-molecule mechanics approaches and the adaptation of the techniques in the investigation of a number of amyloidogenic systems is discussed.
Surfactant effects on amyloid aggregation kinetics.
Determinants of amyloid fibril degradation by the PDZ protease HTRA1.
TLDR
This work analyzed how a single factor, the highly conserved serine protease HTRA1, degrades amyloid fibrils in an ATP-independent manner, allowing productive interaction of aggregated polypeptides with the active site for rapid degradation.
Stability of Transmembrane Amyloid β-Peptide and Membrane Integrity Tested by Molecular Modeling of Site-Specific Aβ 42 Mutations
TLDR
The experimental observation that the altered toxicity arising from mutations in Aβ is not only a result of the altered aggregation propensity, but also originates from modified Aβ interactions with neuronal membranes is supported.
Osmolyte Induced Changes in Peptide Conformational Ensemble Correlate with Slower Amyloid Aggregation: A Coarse-Grained Simulation Study.
TLDR
Simulation of the initial aggregation steps of an amyloid-forming peptide in the presence and absence of the osmolyte sorbitol finds that, compared to pure water as solvent, the presence of Sorbitol induces formation of more aggregates each containing fewer peptides, with an increased tendency toward parallel interpeptide contacts.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 147 REFERENCES
Following the aggregation of amyloid-forming peptides by computer simulations.
TLDR
The authors' simulations indicate that four KFFE peptides adopt a variety of oligomeric states (tetramers, trimers, and dimers) with various orientations of the chains in rapid equilibrium, consistent with all-atom molecular-dynamics simulations in explicit solvent and is sequence dependent.
The interplay of catalysis and toxicity by amyloid intermediates on lipid bilayers: insights from type II diabetes.
TLDR
This review focuses on lipid bilayer-bound intermediates, a class of disease defined by the misfolding and aggregation of functional protein precursors into fibrillar states that contribute to the pathology of many diseases, including type II diabetes, Alzheimer's, and Parkinson's.
On the structural definition of amyloid fibrils and other polypeptide aggregates
  • M. Fändrich
  • Biology, Chemistry
    Cellular and Molecular Life Sciences
  • 2007
TLDR
A structural comparison of amyloid fibrils and other types of polypeptide assemblies is presented and amyloids are defined, based on structural considerations, as fibrillar polyPEptide aggregates with a cross-β conformation.
...
1
2
3
4
5
...